Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 15 Carcinoma, Non-Small-Cell Lung 9 Uterine Cervical Neoplasms 7 Colonic Neoplasms 6 Breast Neoplasms 5 Uterine Cervical Dysplasia 4 Urinary Bladder Neoplasms 4 Papillomavirus Infections 3 Neuroblastoma 3 Melanoma 3 Lung Neoplasms 3 Leukemia, Myeloid, Acute 3 Esophageal Neoplasms 3 Brain Neoplasms 3 Anus Neoplasms 3 Triple Negative Breast Neoplasms 2 Thyroid Neoplasms 2 Squamous Intraepithelial Lesions 2 Rectal Neoplasms 2 Precancerous Conditions 2 Oropharyngeal Neoplasms 2 Neoplasms 2 Mouth Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Liver Neoplasms 2 Leukemia, Myelomonocytic, Acute 2 Leukemia, Monocytic, Acute 2 Leukemia, Megakaryoblastic, Acute 2 Leukemia, Erythroblastic, Acute 2 HIV Infections 2

Interventions

Gemcitabine 13 pembrolizumab 9 Specimen Handling 9 enfortumab vedotin 8 Cisplatin 8 Magnetic Resonance Spectroscopy 7 avelumab 5 Carboplatin 5 vinflunine 4 Nivolumab 4 atezolizumab 3 Immunoglobulin G 3 Disulfides 3 Biopsy 3 eribulin 2 cabozantinib 2 Standard of Care 2 Ramucirumab 2 Radiotherapy 2 Platinum 2 Nephroureterectomy 2 Ipilimumab 2 Doxorubicin 2 Docetaxel 2 CTLA-4 Antigen 2 Bortezomib 2 1,2-diaminocyclohexaneplatinum II citrate 2 vandetanib 1 tremelimumab 1 tocilizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Ureteral Neoplasms × Watchful Waiting × Clear all

NCT03244384 2026-05-29

AMBASSADOR

National Cancer Institute (NCI)

Phase 3 Active not recruiting

Ureteral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡